Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation In Advanced Prostate Can

		Plastic Surgery user forums > Plastic Surgery News
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation In Advanced Prostate Can

Plastic Surgery News Latest Plastic Surgery News

LinkBack

Thread Tools

Display Modes

#1 (permalink)

02-14-2008, 02:36 PM

News Feeder9 News Feeder9 is offline

Senior Member

Join Date: Jun 2007

Posts: 5,209

My Photos: (0)

Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation In Advanced Prostate Can

Ipsen (Paris:IPN) announced that its partner Debiopharm presented the results of a phase III study with its new 6-month formulation of Decapeptyl(R)1, a luteinizing hormone releasing hormone agonist (LHRHa) for the treatment of advanced prostate cancer. The results presented show similar efficacy and safety to the already marketed 1- and 3-month formulations of triptorelin.
More...

« Prostate Cancer Watch And Wait Suggested For Older Men | Boston Globe Examines California Stem Cell Research Program, Effect On Other State I »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts vB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On

All times are GMT. The time now is 04:34 AM.